BEC
PFE icon

Blue Edge Capital’s Pfizer PFE Stock Holding History

Blue Edge Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Sell
8,654
-571
-6% -$14.9K 0.03% 134
2026
Q1 		$259K Buy
9,225
+711
+8% +$18.9K 0.03% 125
2025
Q4 		$212K Buy
+8,514
New +$215K 0.03% 125

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Blue Edge Capital's PFE Position: Q2 2026 in Review

Blue Edge Capital reduced its Pfizer (PFE) stake by 6.2% in Q2 2026, selling an estimated $14.9K and leaving 8,654 shares worth $208K. The position accounts for 0.03% of the portfolio, ranked #134.

Blue Edge Capital first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $259K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Blue Edge Capital held 8,654 shares of Pfizer worth $208K as of Q2 2026.
  • Blue Edge Capital sold 571 Pfizer shares in Q2 2026, an estimated $14.9K.
  • Pfizer made up 0.03% of Blue Edge Capital's portfolio in Q2 2026, its #134 holding.
  • Blue Edge Capital first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Blue Edge Capital's Pfizer position peaked at $259K in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Blue Edge Capital's 13F filing for Q2 2026, filed 17 Aug 2026.